Clinical Trial: A Comparative Sudy Comparing Argatroban® IV vs Desirudin SC for Suspected HIT With or Without Thrombosis Syndrome

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional

Official Title: A Comparative Clinical and Pharmacoeconomic Study Comparing Argatroban® IV vs Desirudin SC for Patients With Suspected Heparin-Induced Thrombocytopenia (HIT)With or W

Brief Summary: Compare Clinical Success and Costs in two Arms

Detailed Summary: Demonstrate clinical and economic utility between the study Arms.
Sponsor: Canyon Pharmaceuticals, Inc.

Current Primary Outcome: New Thrombosis, Amputation, Death, Major and Minor Bleeding [ Time Frame: 30 days ]

Original Primary Outcome: Clinical Utility [ Time Frame: End of Study ]

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Canyon Pharmaceuticals, Inc.

Dates:
Date Received: November 6, 2008
Date Started: September 2008
Date Completion:
Last Updated: January 6, 2013
Last Verified: January 2013